Compare Phapros Tbk. (PEHA) vs Reksa Dana Indeks Mandiri ETF LQ45 (XMLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Phapros Tbk. vs Reksa Dana Indeks Mandiri ETF LQ45 — how do they compare? Phapros Tbk. trades at Rp298 (market cap 250.32B, 116.6K 24h volume), while Reksa Dana Indeks Mandiri ETF LQ45 trades at Rp706 (market cap 9.15B, 300 24h volume). The key difference: Phapros Tbk. is far larger — about 27.4× Reksa Dana Indeks Mandiri ETF LQ45's market cap, and Phapros Tbk. is more actively traded (116.6K versus 300). Which is the better fit depends on your goals.
| PEHA | XMLF | |
|---|---|---|
Market Cap | 250.32B | 9.15B |
Volume | 116.6K | 300 |
Lot | 1.17K | 3 |
Turnover | 34.22M | 211.8K |
Average Price | 293.45 | 706 |
Value | 34.22M | 211.8K |
Indicative Equilibrium Price | 300 | — |
Indicative Equilibrium Volume | 7 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Phapros Tbk.
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →
